Molecular mechanisms supporting a pathogenic role for human polyomavirus 6 small T antigen: Protein phosphatase 2A

Julie H Wu1,2, Rebecca A Simonette1, Harrison P Nguyen1,2

  • 1Department of Dermatology, University of Texas Health Science Center, Houston, Texas.

Journal of Medical Virology
|September 16, 2016
PubMed

Insights

Human Polyomavirus 6 (HPyV6) small tumor antigen activates protein phosphatase 2A (PP2A), driving oncogenic pathways. This mechanism may explain how HPyV6 contributes to secondary skin cancers in BRAF inhibitor melanoma treatments.

Area of Science:

  • Oncology
  • Virology
  • Dermatology

Background:

  • BRAF inhibitors treat melanoma but can cause secondary cutaneous squamous cell carcinoma (cSCC).
  • Human Polyomavirus 6 (HPyV6) proteins are found in BRAF inhibitor-induced cSCCs.
  • The mechanism by which HPyV6 promotes neoplastic growth is unclear.

Purpose of the Study:

  • To investigate the pathogenic mechanism of HPyV6 small tumor (sT) antigen in BRAF inhibitor-induced neoplasms.
  • To elucidate the interaction between HPyV6 sT and cellular proteins involved in cancer development.

Main Methods:

  • Investigated the binding of HPyV6 sT antigen to protein phosphatase 2A (PP2A).
  • Analyzed the role of HPyV6 sT antigen's WFG motif and zinc binding sites in PP2A interaction.
  • Examined the activation of downstream oncogenic pathways (MEK/ERK/c-Jun) by HPyV6 sT-PP2A interaction.

Main Results:

  • HPyV6 sT antigen binds to PP2A via its WFG motif and zinc binding sites.
  • HPyV6 sT antigen activates PP2A.
  • Activation of PP2A by HPyV6 sT leads to the activation of downstream oncogenic pathways, including MEK/ERK/c-Jun.

Conclusions:

  • HPyV6 sT antigen plays a significant role in the pathogenesis of BRAF inhibitor-induced neoplasms.
  • The interaction between HPyV6 sT and PP2A activates oncogenic signaling pathways.
  • This study reveals a novel mechanism for HPyV6 in promoting cancer development.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K